These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
163 related articles for article (PubMed ID: 913873)
1. Phenylbutazone: plasma concentrations and effectiveness in patients with rheumatoid arthritis. Orme ML J Int Med Res; 1977; 5 Suppl 2():40-7. PubMed ID: 913873 [TBL] [Abstract][Full Text] [Related]
2. Plasma concentration of phenylbutazone and its therapeutic effect-studies in patients with rheumatoid arthritis. Orme M; Holt PJ; Hughes GR; Bulpitt CJ; Draffan GH; Thorgeirsson SS; Williams F; Davies DS Br J Clin Pharmacol; 1976 Feb; 3(1):185-91. PubMed ID: 788739 [TBL] [Abstract][Full Text] [Related]
3. A double-blind comparison of phenylbutazone and suxibuzone, a prodrug of phenylbutazone, in rheumatoid arthritis. Mizushima Y; Shiokawa Y; Honma M; Kageyama T Int J Tissue React; 1983; 5(1):35-9. PubMed ID: 6345427 [TBL] [Abstract][Full Text] [Related]
4. Clinical evaluation of ketoprofen (Orudis) in rheumatoid arthritis. Results of a multi-centre, double-blind, cross-over trial against phenylbutazone. Sydnes O; Brath HK; Haerum LB; Straume S Scand J Rheumatol Suppl; 1976; 1976(0):119-22. PubMed ID: 790547 [TBL] [Abstract][Full Text] [Related]
5. Butacote and naproxen: a comparison of effectiveness in rheumatoid arthritis. Million R J Int Med Res; 1977; 5 Suppl 2():77-80. PubMed ID: 334609 [TBL] [Abstract][Full Text] [Related]
6. A new pyrazolidine derivative - benetazone spofa - in short- and medium-term treatment of rheumatoid arthritis. (Double-blind comparative study with phenylbutazone). Pavelka K; Vojtisek O; Bremová A; Kauková D; Hándlová D Int J Clin Pharmacol Biopharm; 1976 Jul; 14(1):20-8. PubMed ID: 61951 [TBL] [Abstract][Full Text] [Related]
7. A double-blind cross-over study of ketoprofen and phenylbutazone in rheumatoid arthritis. Peltola P Scand J Rheumatol Suppl; 1976; 1976(0):111-3. PubMed ID: 790546 [TBL] [Abstract][Full Text] [Related]
8. A comparative clinical study of a new antirheumatic agent, tolfenamic acid (Clotam), and phenylbutazone in rheumatoid arthritis. Nyfos L Scand J Rheumatol Suppl; 1979; (24):5-7. PubMed ID: 373085 [TBL] [Abstract][Full Text] [Related]
9. A phenylbutazone dose-finding study in rheumatoid arthritis. Bird HA; Leatham PA; Lowe JR; Downie WW; Fowler PD; Wright V Eur J Clin Pharmacol; 1983; 24(6):773-6. PubMed ID: 6884415 [TBL] [Abstract][Full Text] [Related]
10. A comparison of a sustained release preparation of tiaprofenic acid with the conventional tablet formulation and a placebo in rheumatoid arthritis. Essigman W; Lambert J; Sheldon P; Sweetman BJ; Wojtulewski J Int J Clin Pharmacol Res; 1987; 7(4):251-7. PubMed ID: 3596867 [TBL] [Abstract][Full Text] [Related]
11. A double-blind randomised controlled trial of droxicam versus indomethacin in rheumatoid arthritis. Sánchez Andrada S; Rodríguez Valverde V Eur J Rheumatol Inflamm; 1991; 11(4):15-20. PubMed ID: 1365485 [TBL] [Abstract][Full Text] [Related]
12. Correlation of aryl hydrocarbon hydroxylase activity of human lymphocyte cultures and plasma elimination rates for antipyrine and phenylbutazone. Kellermann G; Luyten-Kellermann M; Horning M; Stafford M Drug Metab Dispos; 1975; 3(1):47-50. PubMed ID: 234834 [TBL] [Abstract][Full Text] [Related]
13. A double-blind crossover comparison of tolmetin sodium and phenylbutazone in the treatment of rheumatoid arthritis. Cardoe N; Steele CE Curr Med Res Opin; 1976-1977; 4(10):688-94. PubMed ID: 800970 [TBL] [Abstract][Full Text] [Related]
14. [Infulence of pyrasanone on the index of articular radioisotope (tc99m) uptake in rheumatoid arthritis]. Grimaldi MG; Bonora R Minerva Med; 1975 Sep; 66(56):2781-5. PubMed ID: 1174381 [TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of phenylbutazone in mature Holstein bulls: steady-state kinetics after multiple oral dosing. Williams RJ; Boudinot FD; Smith JA; Knight AP Am J Vet Res; 1990 Mar; 51(3):371-5. PubMed ID: 2316912 [TBL] [Abstract][Full Text] [Related]
16. [Clinical study on a new acetylsalicylic acid/paracetamol preparation with gastric acid resistant coating (Safapryn), and on two various phenylbutazone dosages in patients with primary chronic polyarthritis as based on a new evaluation method]. Brooks PM; Walker JJ; Lee P; Bell AM; Buchanan WW; Fowler PD; Anderson JA Z Rheumatol; 1975; 34(9-10):350-65. PubMed ID: 1106038 [TBL] [Abstract][Full Text] [Related]
17. Investigation of phenylbutazone in synovial fluid. Farr M; Willis JV J Int Med Res; 1977; 5 Suppl 2():26-9. PubMed ID: 913871 [TBL] [Abstract][Full Text] [Related]
18. Rheumatoid arthritis: workload and outcome over 10 years. Capell HA; Murphy EA; Hunter JA Q J Med; 1991 Jun; 79(290):461-76. PubMed ID: 1946927 [TBL] [Abstract][Full Text] [Related]
19. Long-term therapy with the new glucocorticosteroid deflazacort in rheumatoid arthritis. Double-blind controlled randomized 12-months study against prednisone. Eberhardt R; Krüger K; Reiter W; Gross W; Zwingers T Arzneimittelforschung; 1994 May; 44(5):642-7. PubMed ID: 8024639 [TBL] [Abstract][Full Text] [Related]
20. Meclofenamate sodium, phenylbutazone, and naproxen in the treatment of degenerative joint disease. Report of a placebo-controlled double-blind clinical comparison. López Sánchez J; Yañez Marchena G Arzneimittelforschung; 1983; 33(4A):653-6. PubMed ID: 6349651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]